- Home
- INV vs CATX Comparison
INV vs CATX Comparison
Compare INV & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INV
- CATX
- Stock Information
- Founded
- INV 2015
- CATX 1983
- Country
- INV United States
- CATX United States
- Employees
- INV N/A
- CATX N/A
- Industry
- INV
- CATX Medical/Dental Instruments
- Sector
- INV
- CATX Health Care
- Exchange
- INV NYSE
- CATX Nasdaq
- Market Cap
- INV 662.9M
- CATX 782.7M
- IPO Year
- INV N/A
- CATX N/A
- Fundamental
- Price
- INV $12.37
- CATX $3.51
- Analyst Decision
- INV
- CATX Strong Buy
- Analyst Count
- INV 0
- CATX 9
- Target Price
- INV N/A
- CATX $17.25
- AVG Volume (30 Days)
- INV 131.2K
- CATX 1.2M
- Earning Date
- INV 02-15-2025
- CATX 02-12-2025
- Dividend Yield
- INV N/A
- CATX N/A
- EPS Growth
- INV N/A
- CATX N/A
- EPS
- INV N/A
- CATX N/A
- Revenue
- INV $988,000.00
- CATX $1,557,000.00
- Revenue This Year
- INV N/A
- CATX N/A
- Revenue Next Year
- INV N/A
- CATX N/A
- P/E Ratio
- INV N/A
- CATX N/A
- Revenue Growth
- INV 4.88
- CATX N/A
- 52 Week Low
- INV $8.55
- CATX $2.70
- 52 Week High
- INV $18.75
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- INV N/A
- CATX 43.67
- Support Level
- INV N/A
- CATX $3.02
- Resistance Level
- INV N/A
- CATX $3.74
- Average True Range (ATR)
- INV 0.00
- CATX 0.27
- MACD
- INV 0.00
- CATX 0.16
- Stochastic Oscillator
- INV 0.00
- CATX 68.99
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.